Y-Intercept (HK)’s Humacyte HUMA Stock Holding History

Y-Intercept (HK)’s Portfolio HUMA Stock Details HUMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$68.4K	Buy	+87,705	New	+$81.3K	﹤0.01%	1618
2023 Q2	–	Sell	-14,565	Closed	-$45K	–	1468
2023 Q1	$45K	Buy	+14,565	New	+$41.4K	0.01%	1105
2022 Q2	–	Sell	-17,125	Closed	-$121K	–	1003
2022 Q1	$121K	Buy	+17,125	New	+$99.7K	0.03%	659

Other funds holding HUMA

Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Y-Intercept (HK)'s HUMA Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Humacyte (HUMA) in Q2 2026: 87,705 shares worth $68.4K. The stake represents ﹤0.01% of the portfolio and ranks #1618 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in HUMA as recently as Q1 2023.

Y-Intercept (HK) first reported a position in HUMA in Q1 2022 and has held it in 3 quarters since. The position peaked at $121K in Q1 2022. 163 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

Y-Intercept (HK) held 87,705 shares of Humacyte worth $68.4K as of Q2 2026.
Humacyte was a new Y-Intercept (HK) position in Q2 2026.
Humacyte made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1618 holding.
Y-Intercept (HK) first reported a position in Humacyte in Q1 2022 and has held it in 3 quarters since.
Y-Intercept (HK)'s Humacyte position peaked at $121K in Q1 2022.
163 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.